Independence Bank Of Kentucky Logic Bio Therapeutics, Inc. Transaction History

Independence Bank Of Kentucky

  • $460 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 06, 2022
BUY
$0.35 - $0.74 $11,243 - $23,772
32,125 Added 314.95%
42,325 $15,000
Q1 2022

Apr 14, 2022
SELL
$0.61 - $2.49 $1,631 - $6,660
-2,675 Reduced 20.78%
10,200 $7,000
Q4 2021

Jan 26, 2022
BUY
$2.2 - $4.53 $28,325 - $58,323
12,875 New
12,875 $30,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email